| Recruitment status | No longer recruiting |
| Unique ID issued by UMIN | UMIN000007409 |
| Receipt No. | R000006943 |
| Official scientific title of the study | Feasibility study of S-1 and CDDP chemotherapy with short hydration for advanced Gastric Cancer |
| Date of disclosure of the study information | 2012/03/01 |
| Last modified on | 2017/03/09 (Ver. 3) |
| Basic information | ||
| Official scientific title of the study | Feasibility study of S-1 and CDDP chemotherapy with short hydration for advanced Gastric Cancer | |
| Title of the study (Brief title) | Feasibility study of S-1 and CDDP chemotherapy with short hydration for advanced Gastric Cancer | |
| Region |
|
|
| Condition | |||
| Condition | advanced and/or recurrent gastric cancer | ||
| Classification by specialty |
|
||
| Classification by malignancy | Malignancy | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | To evaluate feasibility of S-1+CDDP chemotherapy with short hydration |
| Basic objectives2 | Safety |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | Phase II |
| Assessment | |
| Primary outcomes | Safety |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | S-1 is orally administered for 21 days followed by 14 days rest according to body surface area. CDDP is administered intravenously in each dosage of level at day 8 . | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1)Histologically proven adenocarcinoma of advanced gastric cancer(included esophagogastric junction)
2)CDDP-naïve patients 3)ECOG Performance status(PS) of 0-1. 4)Age of 20 years or older. 5 ) Life expectancy is less than 3 months 6)no severe organ failure 7) possible to oral intake 8) written informed consent |
|||
| Key exclusion criteria | (1) Patient with administration contraindication of S-1 or CDDP
(2,3,4,5) pts with active co-morbidities including severe conditions of heart diseases, gastric ulcers, infections, ileus, uncontrollable diabetes, hypertension, renal failure, hepatic cirrhosis, active interstitial. (6) Symptomatic pleural effusion or ascites (7) metastasis to the brain (8) Watery diarrhea (9) Symptomatic psychological disease (10)Concomitant therapy with flucytocine or phenytoin (11)Pregnancy or breast feeding (12)Decision as ineligible by principal investigator |
|||
| Target sample size | 50 | |||
| Research contact person | |
| Name of lead principal investigator | Yoshio Naomoto |
| Organization | Kawasaki Medical School |
| Division name | Department of General Surgery |
| Address | 2-6-1, Nakasange, Kita-Ward, Okayama-City, Okayama-Prefecture |
| TEL | 086-225-2111 |
| ynaomoto@med.kawasaki-m.ac.jp | |
| Public contact | |
| Name of contact person | Tomoki Yamatsuji |
| Organization | Kawasaki Medical School |
| Division name | Department of General Surgery |
| Address | 2-6-1 Nakasange, Kita-ku, Okayama City, Okayama, 700-8505, Japan |
| TEL | 086-225-2111 |
| Homepage URL | |
| yama-t@med.kawasaki-m.ac.jp | |
| Sponsor | |
| Institute | NPO Japan Southwest Oncology Research Support Organization (JSWOG) |
| Institute | |
| Department | |
| Funding Source | |
| Organization | None |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | No longer recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000006943 |